Neovasc Inc. Depreciation/Fixed assets

Depreciation/Fixed assets of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation/Fixed assets growth rates and interactive chart.

Highlights and Quick Summary

  • Annual Depreciation/Fixed assets for 2021 was 1.04 (a 110.75% increase from previous year)
  • Annual Depreciation/Fixed assets for 2020 was 0.5 (a 12.22% increase from previous year)
  • Annual Depreciation/Fixed assets for 2019 was 0.44 (a -1.54% decrease from previous year)
  • Twelve month Depreciation/Fixed assets ending March 31, 2022 was 3.64 (a 245.59% increase compared to previous quarter)
  • Twelve month trailing Depreciation/Fixed assets increased by 298.68% year-over-year
Trailing Depreciation/Fixed assets for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
3.64 1.05 1.0 0.91
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation/Fixed assets of Neovasc Inc.

Most recent Depreciation/Fixed assetsof NVCN including historical data for past 10 years.

Interactive Chart of Depreciation/Fixed assets of Neovasc Inc.

Neovasc Inc. Depreciation/Fixed assets for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 1.04
2020 0.5
2019 0.44
2018 0.45
2017 0.33
2016 0.48
2015 0.14
2014 0.13
2013 0.12
2012 0.09
2011 0.07

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.